drugset / Trial / NCT06604351
Bronchoscopic Cryoablation Combined With Chemo-Immunotherapy in NSCLC With Central Airway Obstruction
NaSingle-groupOpen-labelTreatment
Summary
This study aimed to evaluate the efficacy and safety of bronchoscopic cryoablation combined with sintilimab plus platinum-based chemotherapy as First-line Treatment for locally advanced or metastatic NSCLC with central airway obstruction.
Timeline
- Start
- 2024-09-15
- Primary completion
- 2027-10-31
- Completion
- 2029-05-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carboplatin | Small molecule | — | — |
| Subject | Nab-paclitaxel | Small molecule | 260 mg/m2 | — |
| Subject | Sintilimab | Monoclonal antibody | 200 mg | — |